Purchase Order 36C24225P0094
Award Date
10/16/24
Potential Completion Date
1/16/25
Potential Value
$13K
Federal Agency
Veterans Integrated Service Network 2
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Belle Isle, FL 32809, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $13,242.99 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract is for the delivery of the medication Jynarque (tolvaptan) to the VA's Veterans Integrated Service Network 2 (VISN 2). The award has no set-aside designation, indicating it is open to all qualified vendors. The performance period runs from the award date of April 30, 2025 through the...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract is for the delivery of the medication Jynarque (tolvaptan) tablets to the VA's Veterans Integrated Service Network 2 (VISN 2) facilities. The contract has a ceiling value of $13,242.99 and a period of performance through August 27, 2025. The contract does not...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract, valued at $13,242.99, is for the delivery of the medication Jynarque (tolvaptan) 45mg/15mg tablets to the VA's Veterans Integrated Service Network (VISN) 2. The contract is not set aside for any specific business type, and there are no indications of subcontractors....
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 2 to Walgreens Specialty Pharmacy, LLC, a division of the Walgreens retail pharmacy chain, for the supply of Jynarque (tolvaptan) 45/105mg tablets. The contract has a ceiling value of $12,580.72 and a period of performance through October 18, 2024. Walgreens Specialty Pharmacy is the prime contractor on this contract, with no subcontractors or set-aside...
This federal contract award, with an ID of 36C24225P0469, was issued by the Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs (VA) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The $13,242.99 firm fixed-price purchase order is for the delivery of the medication Jynarque (tolvaptan) 45mg/15mg tablets. This award does not have a set-aside designation, meaning it was open to all qualified vendors. The contract has an...
This federal contract award, valued at $12,580.72, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to the prime contractor, Walgreens Specialty Pharmacy, LLC (doing business as Walgreens). The contract is for the delivery of the medication Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease. This is a firm fixed-price purchase order with a completion date of February 13, 2025. Walgreens Specialty...
This federal contract award, with ID 36C24225P0619, was issued by the Veterans Health Administration (VHA) under the Department of Veterans Affairs (VA) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The $13,242.99 firm fixed-price purchase order is for the supply of the medication Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease. The contract has an ultimate completion date of May 19, 2025 and was awarded on...
This federal contract award, valued at $12,580.72, was issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to Walgreens Specialty Pharmacy, LLC, a division of the broader Walgreens retail pharmacy chain. The contract is a firm fixed price purchase order for the medication Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease. This is one of several similar contracts Walgreens Specialty Pharmacy has received from...
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Walgreens Specialty Pharmacy, LLC, a for-profit organization, to provide the specialty pharmaceutical product JYNARQUE to the Puget Sound VA Health Care System (VAHCS). The contract has a potential value of $312,685.57 and a period of performance through September 30, 2023. No set-aside designation was used for this award. Walgreens Specialty Pharmacy,...
This is a federal contract award with the ID 36C24225P0419, issued by the U.S. Department of Veterans Affairs (VA) to the prime contractor Walgreens Specialty Pharmacy, LLC (doing business as Walgreens). The contract is for the supply of the pharmaceutical product Jynarque (tolvaptan) 45mg/15mg tablets, which is used to treat autosomal dominant polycystic kidney disease. The contract is a firm fixed price purchase order with a ceiling value of $13,242.99 and an ultimate completion date of...